Bridgebio Oncology Therapeutics, Inc. (BBOT)

8.53 +0.16 (+1.91%) USD  |  NASDAQ  |  May 27, 16:00
8.51 -0.02 (-0.23%) After-Hours: 20:00
More

Bridgebio Oncology Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for BBOT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Praxis Precision Medicines, Inc. Upgrade
Erasca, Inc. Upgrade
Bicara Therapeutics, Inc. Upgrade
Amgen, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade